Publications by authors named "Steven D Linton"

Claim this Profile
C
Caspase inhibitors: a pharmaceutical industry perspective.
Steven D Linton

Curr Top Med Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-class pan caspase inhibitor developed for the treatment of liver disease.
Steven D Linton, Teresa Aja, Robert A Armstrong, Xu Bai, Long-Shiuh Chen

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads.
Brett R Ullman, Teresa Aja, Ning Chen, Jose-Luis Diaz, Xin Gu, Steven D Linton

Bioorg Med Chem Lett· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.
Steven D Linton, Teresa Aja, Peter R Allegrini, Thomas L Deckwerth, Jose-Luis Diaz

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimization.
Steven D Linton, Donald S Karanewsky, Robert J Ternansky, Joe C Wu, Brian Pham

Bioorg Med Chem Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization.
Steven D Linton, Donald S Karanewsky, Robert J Ternansky, Ning Chen, Xian Guo

Bioorg Med Chem Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis